Skip to Main Navigation
Skip to Page Content

Scientific Review of Tamoxifen

CASRN 10540-29-1
Status: Listed in the Report on Carcinogens (RoC)

Primary Uses or Exposures: Tamoxifen is used as an anti-estrogen drug in the palliative treatment of breast cancer and to reduce the incidence of breast cancer in women at high risk of this disease.

Background Document

Public Comments


Note on Accessibility: Persons with disabilities or using assistive technology may find some documents are not fully accessible. For assistance, email us or use our contact form and identify the documents/pages for which access is required. We will assist you in accessing the content of these files. NIEHS has helpful information on accessibility.